Science & Enterprise subscription

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn
INSTAGRAM

Scientists, Investors Form $100M+ Tech Venture Fund

Pen and calculator

A group of entrepreneurs and leading scientists in the U.K. unveiled a venture investment fund that plans to back start-up companies developing a wide range of ground-breaking technologies. . . . → Read More: Scientists, Investors Form $100M+ Tech Venture Fund

Genomics-Blockchain Company Launches, Raises $4.3 Million

Blockchain network graphic

A new enterprise that promises to collect and protect a person’s genomic data with blockchain technology is starting up with the help of a genomics legend and $4.3 million in seed financing. . . . → Read More: Genomics-Blockchain Company Launches, Raises $4.3 Million

Biotechs Collaborate on More Precise Gene, Cell Cancer Therapies

Mountain bluebird

Two biotechnology enterprises developing cancer treatments are pooling their efforts to develop therapies aimed at more specific targets across a range of solid tumor types. . . . → Read More: Biotechs Collaborate on More Precise Gene, Cell Cancer Therapies

Can You Make More Money With Your Trades?

All you need to do is know where to invest, when to invest, and the things that can help you make more money. . . . → Read More: Can You Make More Money With Your Trades?

Cosmetic Dentistry – A Worthy Investment In 2018?

The demand for cosmetic dentistry is still very much there, and the industry is experiencing different trends and developments in technology that is keeping the market growing. . . . → Read More: Cosmetic Dentistry – A Worthy Investment In 2018?

Pfizer, Biotech Partner on RNA Flu Vaccine

3-D print of influenza virus

A biotechnology company in Germany and drug maker Pfizer are developing a vaccine to prevent seasonal influenza using messenger RNA that instructs cells on production of proteins. . . . → Read More: Pfizer, Biotech Partner on RNA Flu Vaccine

Start-Up to Tackle Neurodegenerative Diseases, Raises $31 Million

Magnolia Neuroscience

A new company is forming to develop treatments that protect against destruction of brain cells in Alzheimer’s disease and comparable nerve damage from chemotherapy. . . . → Read More: Start-Up to Tackle Neurodegenerative Diseases, Raises $31 Million

Infographic – U.S. Falling Way Behind on 5G

5G development

The success of mobile devices depends on their underlying technologies, with the next generation of mobile standards known as 5G in the queue. . . . → Read More: Infographic – U.S. Falling Way Behind on 5G

Start-Up Developing Regenerative Liver Disease Treatments

Damaged liver cells

A new enterprise founded by scientists, is underway developing treatments for advanced liver disorders that combine new drugs with cell and gene therapies to restore or replace liver functions. . . . → Read More: Start-Up Developing Regenerative Liver Disease Treatments

Biotechs Partner on Antibody, T-Cell Cancer Therapies in $100M Deal

T-cells illustration

Two biotechnology companies with complementary technologies plan to create treatments for cancer that harness and modify cells from the immune system delivered with benign viruses. . . . → Read More: Biotechs Partner on Antibody, T-Cell Cancer Therapies in $100M Deal